Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2

Spike-specific antibodies contribute significantly to the neutralising activity against SARS-CoV-2 and are important for the therapeutic effect of convalescent plasma. B.1.1.7 is a recently emerged variant of SARS-CoV-2 that has several mutations in the gene encoding for the spike-protein. To assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Katharina, Girl, Philipp, Giebl, Andreas, von Buttlar, Heiner, Dobler, Gerhard, Bugert, Joachim J., Gruetzner, Stefanie, Wölfel, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282447/
https://www.ncbi.nlm.nih.gov/pubmed/34298379
http://dx.doi.org/10.1016/j.jcv.2021.104912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282447/
https://www.ncbi.nlm.nih.gov/pubmed/34298379
http://dx.doi.org/10.1016/j.jcv.2021.104912

Ejemplares similares